MARKET

VCYT

VCYT

Veracyte
NASDAQ
23.51
-0.71
-2.93%
After Hours: 23.51 0 0.00% 16:04 07/18 EDT
OPEN
24.67
PREV CLOSE
24.22
HIGH
24.67
LOW
22.61
VOLUME
1.61M
TURNOVER
--
52 WEEK HIGH
47.32
52 WEEK LOW
19.73
MARKET CAP
1.84B
P/E (TTM)
56.14
1D
5D
1M
3M
1Y
5Y
1D
Should You Continue to Hold Veracyte Stock in Your Portfolio Now?
NASDAQ · 2d ago
Weekly Report: what happened at VCYT last week (0707-0711)?
Weekly Report · 4d ago
Veracyte Inc. Unveils New Insights into Thyroid Cancer with Afirma GRID Studies at ENDO 2025
Reuters · 07/08 20:05
Tempus AI Boosts R&D Efforts Through Wide-Ranging Product Launches
NASDAQ · 07/07 13:55
Weekly Report: what happened at VCYT last week (0630-0704)?
Weekly Report · 07/07 10:01
Weekly Report: what happened at VCYT last week (0623-0627)?
Weekly Report · 06/30 10:04
Weekly Report: what happened at VCYT last week (0616-0620)?
Weekly Report · 06/23 10:01
Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internet
Benzinga · 06/21 04:19
More
About VCYT
Veracyte, Inc. is a global diagnostics company. The Company enables clinicians with insights they need to guide and help patients to diagnose and treat cancer. The Veracyte Diagnostics Platform delivers cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and an evidence-generation engine, which drives durable reimbursement and guideline inclusion for its tests, along with new insights to support continued innovation and pipeline development. The Company offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna) and bladder cancer (Decipher Bladder). It has developed the noninvasive Percepta Nasal Swab test to help physicians accurately and quickly determine lung cancer risk. All of its tests are serviced through its own Clinical Laboratory Improvement Amendments (CLIA) certified laboratories in South San Francisco, California, San Diego, California and Austin, Texas.

Webull offers Veracyte Inc stock information, including NASDAQ: VCYT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCYT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCYT stock methods without spending real money on the virtual paper trading platform.